41 Stocks Moving In Monday’s Mid-Day Session
Gainers
Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3 earnings results.
20 Stocks Moving in Monday’s Pre-Market Session
Gainers
Creative Realities, Inc. (NASDAQ: CREX) rose 132.9% to $3.40 in pre-market trading as the company reported a merger with Reflect Systems on Friday.
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
EyePoint Pharma Highlights Presentation Of Prelim. Data From Phase 1 DAVIO Trial, YUTIQ CALM Registry Study At American Society Of Retina Specialists Meeting
– 3-month safety data from DAVIO trial continues to demonstrate EYP-1901 is well-tolerated in eyes with wet AMD –
– YUTIQ® CALM registry study collecting real-world data on patients with
EyePoint Sets its Sights on Developing Treatments Improving the Lives of Eye Disease Sufferers
Photo Credit: EyePoint Pharmaceuticals
EyePoint Pharma Reports Will Present Data At American Academy Of Ophthalmology Meeting
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that a
EyePoint Sets its Sights on Continued Trial Success in Developing Treatments Improving the Lives of Eye Disorder Sufferers
Photo by Brands&People on Unsplash
EyePoint Pharmaceuticals Q2 EPS $(0.35) Beats $(0.43) Estimate, Sales $8.70M Miss $9.13M Estimate
EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.43) by 18.6 percent. This is a 250 percent decrease over losses of $(0.10) per share
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.